key: cord-1035388-qgvue8yw authors: Liu, Lei; Liu, Wanbing; Wang, Shengdian; Zheng, Shangen title: A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients date: 2020-03-08 journal: nan DOI: 10.1101/2020.03.06.20031856 sha: 610549c879c62efc42f2ad32f63c65b25d8931c7 doc_id: 1035388 cord_uid: qgvue8yw Background The outbreak of the recently emerged novel corona virus disease 2019 (COVID-19) poses a challenge for public health laboratories. We aimed to evaluate the diagnostic value of serological assay for SARS-CoV-2. Methods A newly-developed ELISA assay for IgM and IgG antibodies against N protein of SARS-CoV-2 were used to screen the serums of 238 admitted hospital patients with confirmed or suspected SARS-CoV-2 infection from February 6 to February 14, 2020. SARS-CoV-2 RNA was detected by real time RT-PCR on pharyngeal swab specimens. Findings Of the 238 patients, 194 (81.5%) were detected to be antibody (IgM and/or IgG) positive, which was significantly higher than the positive rate of viral RNA (64.3%). There was no difference in the positive rate of antibody between the confirmed patients (83.0%, 127/153) and the suspected patients (78.8%, 67/85) whose nucleic acid tests were negative. After the patients were defined to the different stages of disease based on the day when the test samples were collected, the analysis results showed that the antibody positive rates were very low in the first five days after initial onset of symptoms, and then rapidly increased as the disease progressed. After 10 days, the antibody positive rates jumped to above 80% from less than 50%. On the contrary, the positive rates of viral RNA kept above 60% in the first 11 days after initial onset of symptoms, and then rapidly decreased. In addition, half of the suspected patients with symptoms for 6-10 days were detected to be antibody positive. Interpretation The suspected patients were most likely infected by SARS-CoV-2. Before the 11th day after initial onset of symptoms, nucleic acid test is important for confirmation of viral infection. The combination of serological assay can greatly improve the diagnostic efficacy. After that, the diagnosis for viral infection should be majorly dependent on serological assay. Keywords. SARS-CoV-2; diagnosis; serological assay; nucleic acid test showed that the antibody positive rates were very low in the first five days after initial 45 onset of symptoms, and then rapidly increased as the disease progressed. After 10 46 days, the antibody positive rates jumped to above 80% from less than 50%. On the 47 contrary, the positive rates of viral RNA kept above 60% in the first 11 days after 48 initial onset of symptoms, and then rapidly decreased. In addition, half of the 49 suspected patients with symptoms for 6-10 days were detected to be antibody positive. 50 Interpretation The suspected patients were most likely infected by SARS-CoV-2. 51 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.06.20031856 doi: medRxiv preprint The N protein is responsible for packaging the encapsidated genome into virions, 12,13 76 and acts as a viral RNA silencing suppressor that is beneficial for the viral replication. 77 14 Furthermore, the N protein has high immunogenic activity and is profusely 78 overexpressed during infection, 15 indicating that N protein should be a potential 79 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.06.20031856 doi: medRxiv preprint collection tube was centrifugated at 1000 rpm/min for 5 min after standing at room 124 temperature for 10 minutes. 5 μ L RNA was prepared and used for real time RT-PCR. 125 Real time RT-PCR was performed using the nucleic acid testing kit (Daan, Enzyme-Linked Immunosorbent Assay (ELISA) 144 Serological assay was performed using Enzyme-Linked Immunosorbent Assays 145 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (Fig.1B) , suggesting that the clinically suspected patients, who were viral RNA 208 negative detected by RT-PCR, were mostly infected. 209 To verify the specificity of the ELISA assays, the serum samples from 70 210 randomly-selected ordinary patients and 50 healthy blood donors were simultaneously 211 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.06.20031856 doi: medRxiv preprint detected. Four samples from the ordinary patients were identified as antibody positive 212 (including one dual positive sample, two IgM-positive samples, and one IgG-positive 213 sample) and no positive was found in the samples of healthy blood donors (Fig.1A) . 214 These results confirmed the specificity of the IgG and IgM ELISA assays. 216 To study the diagnostic value of ELISA assay for virus-specific antibodies, CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint Genomic characterisation and epidemiology of 2019 novel coronavirus: 301 implications for virus origins and receptor binding Clinical features of patients infected with 2019 novel coronavirus 304 in Wuhan, China Early Transmission Dynamics in Wuhan, China Nowcasting and forecasting the potential domestic and international 309 spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study A familial cluster of pneumonia associated with the 2019 novel 312 coronavirus indicating person-to-person transmission: a study of a family cluster Severe acute respiratory syndrome A dynamic compartmental model for the Middle East respiratory 317 syndrome outbreak in the Republic of Korea: A retrospective analysis on control interventions and 318 superspreading events A Novel Coronavirus from Patients with Pneumonia in China Assembly of coronavirus spike protein into trimers and its role in epitope 322 expression A structural analysis of M protein in coronavirus 324 assembly and morphology Severe acute respiratory syndrome 326 coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis Modular organization of SARS coronavirus nucleocapsid 329 protein Identification of in vivo-interacting domains of the murine 331 coronavirus nucleocapsid protein The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor 333 of RNA Silencing in Mammalian Cells Nucleocapsid-independent specific viral RNA packaging 335 via viral envelope protein and viral RNA signal Sensitive and specific monoclonal antibody-based capture Day= the day after initial onset of symptoms. Viral RNA + =a positive result detected by real time RT-PCR CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.06.20031856 doi: medRxiv preprint